Quarterly report pursuant to Section 13 or 15(d)

Equity (Details)

v2.4.0.8
Equity (Details) (USD $)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Gross Proceeds: $ 14,998,500  
Payments of Stock Issuance Costs 1,897,164  
Net Proceeds: 13,101,336 0
Underwriter And Aegis Expenses [Member]
   
Payments of Stock Issuance Costs 1,344,055  
Underwriter And Aegis Expenses [Member] | Underwriter Commission [Member]
   
Payments of Stock Issuance Costs 1,049,895  
Underwriter And Aegis Expenses [Member] | Underwriter Expenses [Member]
   
Payments of Stock Issuance Costs 149,985  
Underwriter And Aegis Expenses [Member] | Aegis Legal Fees [Member]
   
Payments of Stock Issuance Costs 80,000  
Underwriter And Aegis Expenses [Member] | Aegis Registration Expenses [Member]
   
Payments of Stock Issuance Costs 7,500  
Underwriter And Aegis Expenses [Member] | Aegis Miscellaneous Expenses [Member]
   
Payments of Stock Issuance Costs 36,675  
Underwriter And Aegis Expenses [Member] | Aegis Road Show Expenses [Member]
   
Payments of Stock Issuance Costs 20,000  
Akers Biosciences Expenses [Member]
   
Payments of Stock Issuance Costs 553,109  
Akers Biosciences Expenses [Member] | Legal Accounting Expenses [Member]
   
Payments of Stock Issuance Costs 393,298  
Akers Biosciences Expenses [Member] | Printing Document Prep [Member]
   
Payments of Stock Issuance Costs 62,101  
Akers Biosciences Expenses [Member] | Registration Expenses [Member]
   
Payments of Stock Issuance Costs 55,946  
Akers Biosciences Expenses [Member] | Road Show Expenses [Member]
   
Payments of Stock Issuance Costs $ 41,764